<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>E药经理人 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-23T23:20:30+08:00</updated>
  <subtitle>我们致力于成为医药行业意见领袖平台，我们记录和观察医药重大商业事件，展现这个行业的复杂和冲突，提供最前线的思想火花。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>恒瑞、信达、君实、百济PD-1谁的销量高？谁能取胜药价谈判？谁的适应症多？谁进治疗指南多？PD-(L)1价格战已在途！</title>
    <updated>2020-11-23T21:23:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/9BuUaUSqSd2zwpnvpUnTPQ</id>
    <link href="https://mp.weixin.qq.com/s/9BuUaUSqSd2zwpnvpUnTPQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>33个MNC集采品种降价，AZ、默沙东、辉瑞等涉及品种最多！</title>
    <updated>2020-11-23T21:23:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/mwHCiJ_bZ_CSHGmZQ0qxsw</id>
    <link href="https://mp.weixin.qq.com/s/mwHCiJ_bZ_CSHGmZQ0qxsw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“使命驱动 诺言必践” 诺和诺德中国发布首份公益白皮书</title>
    <updated>2020-11-23T21:23:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/GENfN8I1Kg1KDxTpUr7sjA</id>
    <link href="https://mp.weixin.qq.com/s/GENfN8I1Kg1KDxTpUr7sjA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创新重构医疗产业：几家欢喜几家愁，一江春水向东流！</title>
    <updated>2020-11-22T17:47:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/O1bDedyApjMAtQze7s7t5w</id>
    <link href="https://mp.weixin.qq.com/s/O1bDedyApjMAtQze7s7t5w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>烂公司说自己并购了一个干细胞、基因诊断就能涨的时代过去了！</title>
    <updated>2020-11-22T17:47:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/sifKIdihU5c5fa6v8VTQGg</id>
    <link href="https://mp.weixin.qq.com/s/sifKIdihU5c5fa6v8VTQGg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>复宏汉霖：中国创新出海“领航者”</title>
    <updated>2020-11-22T17:47:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/JVRIH7L3f3wOgHO9VEdokg</id>
    <link href="https://mp.weixin.qq.com/s/JVRIH7L3f3wOgHO9VEdokg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>集采之下：嘉林与信立泰，相似的故事，不同的结局......</title>
    <updated>2020-11-21T21:02:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/WDm7Fzm0ZWsAKJOpg3XrcA</id>
    <link href="https://mp.weixin.qq.com/s/WDm7Fzm0ZWsAKJOpg3XrcA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>替尼“大爆炸”启示录：36个上市，仅8个国产，仍有企业未收回成本！</title>
    <updated>2020-11-21T21:02:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/RBQO1MRnDf7P0VWhvRiohw</id>
    <link href="https://mp.weixin.qq.com/s/RBQO1MRnDf7P0VWhvRiohw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家医保局：有这些行为将被限制或中止挂网、投标、配送！</title>
    <updated>2020-11-20T21:19:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/xaPRatPzmpOHDqgAkTbjpw</id>
    <link href="https://mp.weixin.qq.com/s/xaPRatPzmpOHDqgAkTbjpw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>参天公司：以中国本土需求为导向，持续贡献中国眼科事业</title>
    <updated>2020-11-20T21:19:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/QLRCgDR8rN05VCkh84dRew</id>
    <link href="https://mp.weixin.qq.com/s/QLRCgDR8rN05VCkh84dRew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>带量采购对医疗健康企业组织与人才管理的影响——怡安翰威特专题研究结果</title>
    <updated>2020-11-20T21:19:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/TiRBbTeXLGvRYeBByzDc-g</id>
    <link href="https://mp.weixin.qq.com/s/TiRBbTeXLGvRYeBByzDc-g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>AZ错失80亿美元生物类似药入场券，与三星韩国合资公司将清算</title>
    <updated>2020-11-20T21:19:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/wQOVGhoMRC-4rmAR054mZQ</id>
    <link href="https://mp.weixin.qq.com/s/wQOVGhoMRC-4rmAR054mZQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>971、君实PD-1曾被争议的快速上市，CDE发文明确了标准</title>
    <updated>2020-11-20T21:19:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/C2WJI3NtRm0y2q3Owp7MKg</id>
    <link href="https://mp.weixin.qq.com/s/C2WJI3NtRm0y2q3Owp7MKg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020全球最具潜力药品TOP10！K药第一，O药落选，T药补位……这家药企占两席</title>
    <updated>2020-11-19T22:48:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/U42zvC9rYdzDwkwJKueuCA</id>
    <link href="https://mp.weixin.qq.com/s/U42zvC9rYdzDwkwJKueuCA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>人类遗传资源监管如何服务新药创新？27日杭州启思会，解惑答疑！</title>
    <updated>2020-11-19T22:48:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/UYNEzb29GmV0fN7h4Q15Vg</id>
    <link href="https://mp.weixin.qq.com/s/UYNEzb29GmV0fN7h4Q15Vg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>投资人视角|处方药网售放开，多政策联动释放百亿空间</title>
    <updated>2020-11-19T22:48:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/t8RK4nF7eaxZVhmmFBju7A</id>
    <link href="https://mp.weixin.qq.com/s/t8RK4nF7eaxZVhmmFBju7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>启思会防疫提示：这类人员需提供核酸检测报告！</title>
    <updated>2020-11-19T22:48:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/8m5eRtCp0hxtCRcxcCspnA</id>
    <link href="https://mp.weixin.qq.com/s/8m5eRtCp0hxtCRcxcCspnA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>基药数量扩到900？重点考虑传染病、肿瘤药？这些调整信号对药企意味着什么？</title>
    <updated>2020-11-18T19:06:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/N_I_i3ElC5W3BjDBB5NZvQ</id>
    <link href="https://mp.weixin.qq.com/s/N_I_i3ElC5W3BjDBB5NZvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>京东健康与一心堂达成战略合作 打造“互联网+医药零售”合作新样板</title>
    <updated>2020-11-18T19:06:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/eNwVfgtKubIf5h6-gDWXSQ</id>
    <link href="https://mp.weixin.qq.com/s/eNwVfgtKubIf5h6-gDWXSQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创立5个月估值65亿，碾压亚盛、华领、歌礼一众新锐，为什么？</title>
    <updated>2020-11-18T19:06:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/HupnwDnfNUYnlyDCYJbMyQ</id>
    <link href="https://mp.weixin.qq.com/s/HupnwDnfNUYnlyDCYJbMyQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>